Mechanistic Biology and its strategic application

This grant funds the training of the next generation of scientists through Doctoral Training Partnerships, not a specific research project. The problem it addresses is a structural one: the UK needs a steady pipeline of skilled researchers to maintain its capacity for fundamental and applied biology. Without sustained investment in postgraduate training, the country risks losing its ability to conduct the mechanistic biology—understanding how living systems work at the molecular and cellular level—that underpins everything from new antibiotics to improved crop yields. The impact is indirect but essential. These partnerships produce PhD graduates who go on to work in universities, biotech companies, agriculture, and pharmaceutical firms. They are the people who will later discover how a protein misfolds in disease, or engineer a yeast to produce a sustainable chemical. The training itself is curiosity-driven: students explore fundamental biological mechanisms without a guaranteed commercial endpoint. But historically, this kind of deep mechanistic understanding has been the foundation for unexpected breakthroughs—such as CRISPR gene editing, which emerged from basic research on bacterial immune systems.